Vimarsana
Biggest News Aggregation in the World

Page 3 - Spain Intensity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Spain Intensity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Spain Intensity Today - Breaking & Trending Today

Continuous Erector Spinae Plane Block Using Programmed Intermittent Bo - Vimarsana News

Continuous Erector Spinae Plane Block Using Programmed Intermittent Bo

Continuous Erector Spinae Plane Block Using Programmed Intermittent Bolus Regimen versus Intravenous Patient-Controlled Opioid Analgesia Within an Enhanced Recovery Program After Open Liver Resection in Patients with Coagulation Disorder: A Randomized, Controlled, Non-Inferiority Trial

An Effective New Treatment for Chronic Back Pain Targets the Nervous System - Vimarsana News

An Effective New Treatment for Chronic Back Pain Targets the Nervous System

A newly developed method called sensorimotor retraining appears to be effective at treating chronic back pain.

Medical Cannabis is an Excellent Pain Reliever for Long-Term Cancer Symptoms, Says New Study - Vimarsana News

Medical Cannabis is an Excellent Pain Reliever for Long-Term Cancer Symptoms, Says New Study

A recent study conducted in Israel revealed that medical cannabis works exceptionally well as a pain reliever for several cancer related symptoms

Source: ibtimes.sg
Erste Patienten in Phase-III-Studie mit Qutenza zur Behandlung von postoperativen neuropathischen Schmerzen aufgenommen - Vimarsana News

Erste Patienten in Phase-III-Studie mit Qutenza zur Behandlung von postoperativen neuropathischen Schmerzen aufgenommen

Aachen (ots) - - Die Studie AV001 soll in den USA eine Zulassungserweiterung für die Behandlung von postoperativen neuropathischen Schmerzen (PSNP) ermöglichen. Qutenza® ist dort derzeit bei Erwachsenen

Axogen Sponsored REPOSE℠ Study Completes Pilot Phase Analysis - Vimarsana News

Axogen Sponsored REPOSE℠ Study Completes Pilot Phase Analysis

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Axogen Sponsored REPOSE℠ Study Completes Pilot Phase Analysis Axogen, Inc.February 18, 2021 GMT ALACHUA, Fla., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced completion of pilot phase analysis for its REPOSE clinical study.  Analysis of the REPOSE study’s 15-subject single arm pilot phase demonstrated that subjects experienced a clinically si...

Source: apnews.com